These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21165531)

  • 1. Bosentan - a previously unrecognised cause of facial telangiectasia.
    Tong PL; Kumarasinghe SP
    Ann Acad Med Singap; 2010 Nov; 39(11):874-5. PubMed ID: 21165531
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological characteristics and clinical efficacy of bosentan].
    Fujimoto K; Ikenoya S
    Nihon Yakurigaku Zasshi; 2005 Dec; 126(6):407-18. PubMed ID: 16462092
    [No Abstract]   [Full Text] [Related]  

  • 3. Bosentan for pulmonary arterial hypertension.
    Drug Ther Bull; 2003 Sep; 41(9):70-2. PubMed ID: 14531210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidden hazards of Bosentan therapy in pulmonary hypertension.
    Sethi S; Sethi R; Wareham C
    Ann Card Anaesth; 2008; 11(2):138; author reply 138-9. PubMed ID: 18603762
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of pulmonary arterial hypertension: a step forward.
    Sharma S
    Chest; 2003 Jul; 124(1):8-11. PubMed ID: 12853493
    [No Abstract]   [Full Text] [Related]  

  • 6. Bosentan: a novel agent for the treatment of pulmonary arterial hypertension.
    O'Callaghan D; Gaine SP
    Int J Clin Pract; 2004 Jan; 58(1):69-73. PubMed ID: 14994973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of pulmonary arterial hypertension: endothelin-receptor antagonists].
    Hoeper MM
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S308-10. PubMed ID: 17139593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan.
    Foley RJ; Metersky ML
    Respiration; 2008; 75(2):211-4. PubMed ID: 16293957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blockade of endothelin receptor with bosentan--a new principle of treatment in pulmonary arterial hypertension].
    Nielsen-Kudsk JE
    Ugeskr Laeger; 2003 Jul; 165(29):2891-4. PubMed ID: 12908360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bosentan].
    Taéron C
    Rev Infirm; 2005 Feb; (108):33-4. PubMed ID: 15816717
    [No Abstract]   [Full Text] [Related]  

  • 11. Bosentan for pulmonary hypertension.
    Dietrich CG; Geier A; Lammert F
    N Engl J Med; 2002 Jul; 347(4):292-4; author reply 292-4. PubMed ID: 12141332
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug eruption due to bosentan in a patient with systemic sclerosis.
    Nagai Y; Yamanaka M; Nishimura S; Nakano A; Hasegawa A; Ishikawa O
    Mod Rheumatol; 2006; 16(3):188-90. PubMed ID: 16767560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of iloprost and bosentan in pulmonary arterial hypertension.
    Saleh JA
    Niger J Med; 2008; 17(1):13-9. PubMed ID: 18390125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bosentan enters market with risk management program.
    Thompson CA
    Am J Health Syst Pharm; 2002 Mar; 59(6):506. PubMed ID: 11908242
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of bosentan for treatment of pulmonary hypertension.
    Raja SG; Dreyfus GD
    Ann Card Anaesth; 2008; 11(1):6-14. PubMed ID: 18182753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review on bosentan, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension.
    Serasli E; Michaelidis V; Kosmas A; Antoniadou M; Tsara V
    Recent Pat Cardiovasc Drug Discov; 2010 Nov; 5(3):184-95. PubMed ID: 20874675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent gastrointestinal bleeding in a patient with Eisenmenger syndrome using bosentan.
    Sari I; Cam H; Dag MS; Durmus E; Kivrak T; Tigen K; Davutoglu V
    Curr Drug Saf; 2013 Sep; 8(4):282-3. PubMed ID: 24102362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bosentan: a dual endothelin receptor antagonist.
    Rubin LJ; Roux S
    Expert Opin Investig Drugs; 2002 Jul; 11(7):991-1002. PubMed ID: 12084009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bosentan may induce arthritis flare in patients with scleroderma concomitantly treated with methotrexate.
    Cozzi F; Ostuni PA; Marotta H; Sfriso P; Favaro M; Todesco S
    Ann Rheum Dis; 2006 May; 65(5):692-3. PubMed ID: 16611872
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term therapy with endothelin-1 antagonist for pulmonary hypertension secondary to systemic sclerosis].
    Shalev L; Langevitz P; Zandman-Goddard G
    Harefuah; 2008 Apr; 147(4):287-9, 376. PubMed ID: 18686806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.